UPDATE : Tuesday, August 14, 2018
Local patents increasingly target obesity by Nam Doo-hyun 2018-08-14 16:26
Who will be first to develop new acute pancreatitis remedy? by Nam Doo-hyun 2018-08-14 10:32
Bio stock slump drags down diagnostics, equipment, reagent companies by Nam Doo-hyun 2018-08-09 14:29
‘Bayer’s liver cancer drug better than expected’ by Nam Doo-hyun 2018-08-06 18:21
2018-listed pharmaceutical, medical shares tank by Nam Doo-hyun 2018-07-31 14:02
Patent approved to predict chemotherapeutic effects for breast cancer patients by Nam Doo-hyun 2018-07-27 11:50
[Exclusive] Invossa patent expired in 6 European countries by Nam Doo-hyun 2018-07-26 11:16
Which multinational drugmaker grew most rapidly in H1? by Nam Doo-hyun 2018-07-25 11:52
Will new patent help detect norovirus easily? by Nam Doo-hyun 2018-07-05 17:24
‘UCB Korea to keep pursuing patient value in neurology’ by Nam Doo-hyun 2018-07-04 14:37
Biopharma stocks listed in H1 perform poorer than non-pharma peers by Nam Doo-hyun 2018-07-03 15:08
‘Government support for dementia tests might be ill-timed’ by Nam Doo-hyun 2018-07-03 11:47
‘Bleeding risk lowest in Eliquis among NOACs for AF patients’ by Nam Doo-hyun 2018-07-02 16:47
BMS Korea wins fight for Eliquis patent by Nam Doo-hyun 2018-06-29 14:41
Prognostic marker for childhood obesity complications wins patent by Nam Doo-hyun 2018-06-27 12:19
Antarctic sea microorganisms; a solution to blood shortage? by Nam Doo-hyun 2018-06-26 14:44
Korea’s drug exports to US, Europe on the rise by Nam Doo-hyun 2018-06-25 16:09
Chong Kun Dang topped in H1 clinical trial by Nam Doo-hyun 2018-06-21 11:11
Over 60% of KOSDAQ biotech firms mark falls in Q1 operating profit by Nam Doo-hyun 2018-06-19 11:43
‘Medytox botulinum toxin worth 600 billion won in China’ by Nam Doo-hyun 2018-06-19 09:26
Back to Top